Search Within

Suresh C Jhanwar

  1. "Breast Medicine Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Breast Medicine Service (7)
  2. Department of Medicine (7)
  3. Solid Tumor Oncology Division (7)
  4. GSK Faculty (6)
  5. Survivorship Research (6)
  6. Clinical Genetics Service (5)

More Groups

People
  1. Kenneth Offit (5)
  2. Larry Norton (4)
  3. Patrick Borgen (3)
  4. Mark Robson (2)
  5. Noah Kauff (2)
  6. Teresa Gilewski (2)

More People

Years
  1. 2012 (1)
  2. 2009 (1)
  3. 2004 (1)
  4. 2002 (1)
  5. 1996 (2)
  6. 1995 (1)
Publications
  1. Nature Genetics (2)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. JAMA - Journal of the American Medical Association (1)
  5. Journal of Clinical Oncology (1)
  6. Leukemia and Lymphoma (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Nature Publishing Group (2)
  3. American Medical Association (1)
  4. American Society of Clinical Oncology (1)
  5. Taylor & Francis Group (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Identification and biological characterization of exon 4 KRAS mutations by MALDI-TOF Mass Spectrometry based genotyping
    Meeting Abstract

    Janakiraman, M.; Zeng, Z.; Chitale, D.; Halilovic, E.; Rosen, N.; Vakiani, E.; Heguy, A.; Ladanyi, M.; Jhanwar, S.; Saltz, L.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Feasibility of breast conserving treatment for breast cancer in women with germline BRCA mutations: A clinic-based series
    Meeting Abstract

    Robson, M.; Holcombe, T.; McCormick, B.; Borgen, P.; Gulati, T.; Jhanwar, S.; Kauff, N.; Hudis, C.; Norton, L.; Offit, K.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers
    Journal Article

    Offit, K.; Gilad, S.; Paglin, S.; Kolachana, P.; Roisman, L. C.; Nafa, K.; Yeugelowitz, V.; Gonzales, M.; Robson, M.; McDermott, D.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
    Journal Article

    Oddoux, C.; Struewing, J. P.; Clayton, C. M.; Neuhausen, S.; Brody, L. C.; Kaback, M.; Haas, B.; Norton, L.; Borgen, P.; Jhanwar, S.; more...
    Nature Genetics (1996)

    Fulltext@MSK | Save
  • Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
    Journal Article

    Neuhausen, S.; Gilewski, T.; Norton, L.; Tran, T.; McGuire, P.; Swensen, J.; Hampel, H.; Borgen, P.; Brown, K.; Skolnick, M.; more...
    Nature Genetics (1996)

    Fulltext@MSK | Save
  • A collaborative survey of 80 mutations in the BRCA1 breast cancer and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening
    Journal Article

    Shattuck- Eidens, D.; McClure, M.; Simard, J.; Labrie, F.; Narod, S.; Couch, F.; Hoskins, K.; Weber, B.; Castilla, L.; Erdos, M.; more...
    JAMA - Journal of the American Medical Association (1995)

    Fulltext@MSK | Save